BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN

BIOtech Now
Andrew Segerman

BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest proposals being considered on Capitol Hill, the need to sustain biomedical innovation, and ways to ensure patients have access to the medicines they need with out-of-pocket costs they can afford.

Watch the full segment below.

Full BIOtech Now Article here

Powered by WPeMatico